Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Para rubber seed oil is a safe and effective treatment for hair loss.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Certain Dibenzo derivatives may help treat prostate cancer.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Mesotherapy for hair loss can cause temporary forehead swelling.

Finasteride helps hair growth but may cause sexual side effects and depression.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Finasteride, Dutasteride, and Minoxidil are effective for hair growth, while new treatments like laser therapy and PRP show promise with few side effects.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.